Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07783113 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07783113 · ClinicalTrials.gov record · last posted 2026-08-27

Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use

Name: Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use — clinical trial record (NCT07783113)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: GLP-1

StatusNot Yet Recruiting

PhaseNot applicable

SponsorFarmoquimica S.A.

Started2026-10

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

A single-center, open-label clinical study to evaluate whether a dietary supplement can reduce hair loss in women with GLP-1-associated telogen effluvium. Participants will use the supplement for 120 days. Researchers will evaluate hair loss, hair density, and hair growth through clinical assessments, hair measurements (trichogram), and participant questionnaires.

Trial Details

NCT Number	NCT07783113
Lead Sponsor	Farmoquimica S.A. Collaborators: Kosmoscience Ciência e Tecnologia Cosmética Ltda
Conditions	Alopecia
Enrollment	48 participants
Start Date	2026-10
Primary Completion	2027-02 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2026-08-27